Business
BioSpectrum Asia
Taiwan allocates budget of NT$24 B for pharma preparedness resilience
Taiwan's President Lai Ching-te recently presided over the seventh meeting of the Healthy Taiwan Promotion Committee.
1 min |
BioSpectrum Asia April 2027
BioSpectrum Asia
Australia provides affordable medicines to help fight complex and chronic illness
Australians living with autoimmune disease, lymphoma, Parkinson's, motor neuron disease and cerebral palsy will have access to new medicines owing to expanded and new listings on the Pharmaceutical Benefits Scheme (PBS), an Australian government programme.
1 min |
BioSpectrum Asia April 2027
BioSpectrum Asia
US FDA releases draft guidance on alternatives to animal testing in drug development
The US Food and Drug Administration (FDA) has issued a draft guidance intended to help drug developers validate new approach methodologies (NAMs) to be used instead of animal testing in drug development, and to bring safe, effective drugs to market sooner based on human-centric data.
1 min |
BioSpectrum Asia April 2027
BioSpectrum Asia
UK sets up Taskforce to deliver urgent action on maternity
Women, babies and families will receive safer and higher-quality care through a new National Maternity and Neonatal Taskforce chaired by the Health and Social Care Secretary in the UK.
1 min |
BioSpectrum Asia April 2027
BioSpectrum Asia
Asia Pacific Must Strengthen Regional Biomanufacturing Ecosystems To Unlock Global Potential
Dr. David Chang, CEO of Taiwan Bio Manufacturing Corp. (TBMC), uses his nearly 30 years of expertise at Genentech, Roche, WuXi, and TBMC to analyze the changing dynamics of global biomanufacturing in an interview with BioSpectrum Asia.
4 min |
BioSpectrum Asia April 2027
BioSpectrum Asia
Charles River Brings APAC's Biomanufacturing Future into Focus
Asia Pacific's biomanufacturing landscape is entering a defining decade, and the inaugural APAC Biomanufacturing Leadership Summit 2026 became the region's most influential gathering for leaders shaping this growth.
1 min |
BioSpectrum Asia April 2027
BioSpectrum Asia
Zydus expands companion diagnostics portfolio with launch of AI-powered CGM
India-based Zydus Lifesciences has announced its new offering companion diagnostics portfolio.
1 min |
BioSpectrum Asia April 2027
BioSpectrum Asia
ADB, Mitra Plumbon ink $25 M deal to expand inclusive healthcare in Indonesia
The Asian Development Bank (ADB) has signed a loan of up to Rp 415 billion (equivalent to $25 million) with PT Mitra Plumbon Healthcare (Mitra Plumbon)-a private healthcare provider to expand access to affordable and quality healthcare in underserved areas of West Java and Central Java, Indonesia.
1 min |
BioSpectrum Asia April 2027
BioSpectrum Asia
IAN Alpha Fund co-leads Rs 70 Cr Series A funding round in Peptris
IAN Alpha Fund, the 2nd in the series of IAN Group's VC funds, along with Speciale Invest, has co-led a Rs 70 crore Series A funding round in Peptris, an India-based AI-powered drug discovery startup.
1 min |
BioSpectrum Asia April 2027
BioSpectrum Asia
ImmunoScape announces MoU for clinical trial with US-based cancer centre
Singapore-based startup ImmunoScape, an A*STAR spin-out backed by Amgen Ventures and EDBI that is developing next-generation TCR-based cancer immunotherapies, has announced the execution of a Memorandum of Understanding (MoU) with a premier NCI-designated Comprehensive Cancer Center in the United States (US), renowned globally for its pioneering history in cellular immunotherapy.
1 min |
BioSpectrum Asia April 2027
BioSpectrum Asia
Singapore sets global first by reaching WHO'S highest classification for medical device regulation
The World Health Organization (WHO) has announced that Singapore's Health Sciences Authority (HSA) has achieved the highest level of regulatory performance for medical devices under WHO's global benchmarking framework.
1 min |
BioSpectrum Asia April 2027
BioSpectrum Asia
World Bank Group approves $135M to strengthen Senegal's health system
The World Bank has approved $135 million in financing to strengthen Senegal's health system, improve health outcomes for women, children & adolescents & provide financial protection for vulnerable populations.
1 min |
BioSpectrum Asia April 2027
BioSpectrum Asia
Korea lays focus on expanding AI in public healthcare
South Korea's Minister of Health and Welfare Jeong Eun Kyeong recently visited Seoul National University Bundang Hospital, and held a policy meeting on expanding artificial intelligence (AI) in public healthcare with the heads of major regional medical institutions, including Seoul National University Hospital, Seoul National University Bundang Hospital, Kyungpook National University Hospital, and Jeonbuk National University Hospital.
1 min |
BioSpectrum Asia April 2027
BioSpectrum Asia
Bridging the Talent Gap in Life Sciences Sector
The life sciences sector is constantly moving forward, with new scientific breakthroughs and technologies changing the way we understand, diagnose, and treat diseases.
2 min |
BioSpectrum Asia April 2027
BioSpectrum Asia
South Korea's Biosimilar Boom Enters High-Stakes 'Third Wave'
Biosimilars are a central part of South Korea's biopharmaceutical strategy.
4 min |
BioSpectrum Asia April 2027
BioSpectrum Asia
WHO launches first-ever implementation handbook to accelerate hepatitis elimination
The World Health Organization (WHO) has released a landmark consolidated guidance and implementation handbook on hepatitis B and C, to support countries to expand prevention, testing, treatment, service delivery and programme monitoring, through a comprehensive public health approach.
1 min |
BioSpectrum Asia April 2027
BioSpectrum Asia
China approves Ecnoglutide injection for chronic weight management
Hangzhou Sciwind Biosciences has announced that China's National Medical Products Administration has approved Ecnoglutide injection for chronic weight management in Chinese adults with overweight or obesity.
1 min |
BioSpectrum Asia April 2027
BioSpectrum Asia
Africa and Japan sign cooperation agreement to strengthen global health security
The Africa Centres for Disease Control and Prevention (Africa CDC) and the Japan Institute for Health Security (JIHS) have signed a Memorandum of Cooperation (MOC) to strengthen bilateral collaboration in health security, infectious disease control, research, and public health capacity development.
1 min |
BioSpectrum Asia April 2027
BioSpectrum Asia
India's BioEconomy grows over $195 B in 2025
The India BioEconomy Report (IBER) 2026, developed by the Association of Biotechnology Led Enterprises (ABLE), was unveiled by Union Minister of State (Independent Charge) Science & Technology Dr Jitendra Singh, at the 14th Foundation Day celebration of Biotechnology Industry Research Assistance Council (BIRAC), in New Delhi on March 19, 2026.
1 min |
BioSpectrum Asia April 2027
BioSpectrum Asia
Strides Pharma buys & in-licenses generic brands from Sandoz for $12M
India-based Strides Pharma Science has announced that its step-down subsidiary, Strides Pharma International AG (SPIAG), has entered into definitive agreements with Sandoz AG, Switzerland and its group entities for the acquisition and in-licensing of a portfolio of branded generic products across Sub-Saharan Africa (SSA).
1 min |
BioSpectrum Asia April 2027
BioSpectrum Asia
China's Robust Elderly Care and Equity Policy
China’s 15th Five-Year Plan (2026-2030), announced on March 5 and approved on March 13 during the fourth session of the 14th National People’s Congress, outlines a comprehensive strategy for advancing economic and social development.
2 min |
BioSpectrum Asia April 2027
BioSpectrum Asia
Lucence, DxD Hub and NCCS launch Al-driven cancer diagnostics research collaboration
Precision oncology firm Lucence, with Diagnostics Development Hub (DxD Hub), hosted by the Agency for Science, Technology and Research (A*STAR), Singapore and the National Cancer Centre Singapore (NCCS), have officially launched UNITED 2.0, a S$6 million research collaboration to develop a next-generation, clinical grade cancer profiling test with the goal of advancing the future of precision diagnostics.
1 min |
BioSpectrum Asia April 2027
BioSpectrum Asia
"Structured 3-6-month programmes ensure scale through digital modules and depth through immersive lab experience producing industry-ready talent"
Cytiva has strengthened its India presence with a significant investment in 30,000 sq. ft. Fast Track Process Development Services (PDS) facility, in Bengaluru aimed at accelerating biologics development, bridging skill gaps, and supporting regulatory compliance.
2 min |
BioSpectrum Asia April 2027
BioSpectrum Asia
Guardant Health launches Shield Multi-Cancer Detection Test in APAC market
Guardant Health, Inc., a leading precision oncology company, has announced the launch of the Shield multi-cancer detection (MCD) laboratory developed test (LDT) in multiple markets in Asia.
1 min |
BioSpectrum Asia April 2027
BioSpectrum Asia
Australia's Viral Vector Manufacturing Facility enters into licensing agreement with OXB
OXB, a global quality and innovation-led cell & gene therapy CDMO, has entered into a licensing & option agreement with Viral Vector Manufacturing Facility (VVMF), an Australian contract development & manufacturing organisation & the country's first commercial manufacturing facility of its kind.
1 min |
BioSpectrum Asia April 2027
BioSpectrum Asia
Frontier Biotech inks $963 M deal with GSK for small interfering RNA therapeutics
China-based Frontier Biotechnologies Inc. has entered into an exclusive licensing agreement with GSK, a global biopharma company.
1 min |
BioSpectrum Asia April 2027
BioSpectrum Asia
Translating Cell And Gene Therapy Innovation Into Scalable Manufacturing Requires Early Strategic Planning
Sam Chuang, PhD, Executive Director at Charles River, having experience spanning academic research, translational development, and viral vector CDMO operations discusses the quickly changing cell and gene therapy scene in Asia Pacific in an interview with BioSpectrum Asia.
3 min |
BioSpectrum Asia April 2027
BioSpectrum Asia
India–EU FTA Paves Way for Expanded Healthcare Trade
On January 27, 2026, after years of negotiations, India and the European Union announced a landmark Free Trade Agreement.
4 min |
BioSpectrum Asia March 2026
BioSpectrum Asia
PreferCo and Glatt to open CoE for precision fermentation bioprocess scale-up in India
In a major boost to Government of India's BioE3 push, German major Glatt and India-based startup PreferCo have announced the launch of \"PreferCo-Glatt Centre of Excellence (CoE) for Bioprocess Scale-Up\" in Hyderabad's Genome Valley.
1 min |
BioSpectrum Asia March 2026
BioSpectrum Asia
Women's Health Surge in APAC
The rising burden of diseases such as ovarian cancer, breast cancer, cervical cancer, infertility, etc. is emerging as the key driver of the women's healthcare market across the globe. While North America led the women healthcare market in 2025, Asia Pacific (APAC) is expected to witness the fastest growth this year onwards. As a result, governments across the APAC region, are recognising the importance of women's health and are launching initiatives, particularly under female leaders, to improve access to healthcare services. Moreover, a number of women-led startups are now developing new solutions to address this growing burden of women-associated diseases in the APAC region. Let's take a closer look.
6 min |